EGFR and cancer: The KEGG enrichment analysis suggested these drugs mainly work through multiple pathways in pathways in cancer, endocrine resistance, human cytomegalovirus infection, EGFR tyrosine kinase inhibitor resistance, proteoglycans in cancer.